Espervita Therapeutics, a biotechnology company developing targeted metabolic reprogramming therapies, announced the publication in Cell Metabolism of groundbreaking preclinical data demonstrating ...

Researchers developed a way to directly reprogram human glial cells into PV interneurons without passing through a stem‑cell stage.

ME Therapeutics Holdings Inc. will attend the 44th annual JP Morgan Healthcare Conference from January 12 to 15, 2026 in San ...

Alzheimer’s may advance by breaking the brain’s internal clock—and resetting it could help fight the disease. Alzheimer’s disease often interferes with a person’s normal daily patterns. Early warning ...

Commission took multiple actions during its Dec. 31 meeting, including approving payment for a third-party forensic auditor ...

Congress has unveiled a new package of bills to fund some agencies through fiscal 2026, the latest bipartisan breakthrough as ...

Researchers at Lund University in Sweden have created a method that makes it possible to transform the brain’s support cells ...

Blue Falcon and Dynomutt #5 hits stores Wednesday! The dynamic duo faces their climactic finale as chaos threatens Big City.

Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies. A new study ...

Janux Therapeutics develops intratumoral immuno-oncology therapies as nasdaq 100 index discussions highlight biotech ...

The minibus spending package generally seeks modest spending reductions for covered agencies, but departs from the Trump ...

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...